MALAT1 and metastatic malignant neoplasm: Studies including patient cohorts exhibiting a metastatic cancer phenotype have noted increased levels of MALAT1 in high-risk metastatic tumors compared to low risk tumors (Schmidt et al., 2011; Ying et al., 2012; Han et al., 2013).